Management of Aphthous Ulcers After Taking Mobic (Meloxicam)

Immediate Action: Drug Discontinuation

The American College of Gastroenterology recommends stopping meloxicam (Mobic) immediately, as NSAIDs are well-documented to cause oral ulcerations, and evaluate whether the NSAID is truly necessary or if alternative pain management strategies can be employed 3

The American Academy of Oral Medicine recommends beginning with topical corticosteroids as primary therapy, which are the most effective first-line agents for aphthous ulcers, and applying clobetasol gel or ointment 0.05% directly to dried lesions twice daily 1, 2
For multiple or widespread ulcers, the American Academy of Oral Medicine recommends using betamethasone sodium phosphate 0.5 mg dissolved in 10 mL water as a rinse-and-spit solution four times daily 1, 2, 4

The American Pain Society recommends implementing aggressive pain control to maintain oral intake and quality of life, and using benzydamine hydrochloride rinse or spray every 3 hours, particularly before meals 1, 2, 4
The American Pain Society also recommends using viscous lidocaine 2% applied topically 3-4 times daily for severe pain 1, 2

The American Dental Association recommends cleaning the mouth daily with warm saline mouthwashes to reduce bacterial colonization 1, 2
The American Dental Association also recommends using antiseptic oral rinses such as 0.2% chlorhexidine digluconate mouthwash twice daily 1, 2, 4

The Academy of Nutrition and Dietetics recommends soft, moist foods served at room temperature or cold 5, 6

The American Academy of Oral Medicine recommends considering intralesional triamcinolone injections (weekly, total dose 28 mg) for non-responsive ulcers 1, 4
The American Academy of Oral Medicine also recommends systemic corticosteroids (prednisone/prednisolone 30-60 mg or 1 mg/kg for 1 week with tapering over the second week) for highly symptomatic cases 1, 2, 4

The American Academy of Oral Medicine recommends referring to a specialist if ulcers persist beyond 2 weeks or do not respond to 1-2 weeks of treatment, as this warrants biopsy to exclude malignancy 1, 4

The American Academy of Oral Medicine recommends not prematurely tapering corticosteroids before disease control is established 1
The American Gastroenterological Association recommends not restarting meloxicam or switching to another traditional NSAID without considering the risk-benefit ratio, as cross-reactivity may occur 3